As a proof of concept, we corroborated the clinical relevance of the increased dosage effect of PLCB4 gene in human neoplasms for the first time, highlighting the presumable conversion of copy gain into upregulated mRNA and overexpressed protein in an aggressive subset of GISTs. Here, PLCB4 is linked to neoplasm.